INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.70B / 21S · 11 late91 trades$26.34M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 33S33 trades$5.33M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  7. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  8. SELLULCCFrontier Group Holdings, Inc.Nov 5 – Nov 117 insiders$1.31M

Form 4 transactions

19,519 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
22
TA
Thompson Travis AlvinCHIEF ACCOUNTING OFFICER
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$7,192
1,115 sh
Jan 5, 2026
Page 402 of 488
← PrevNext →
Jan 6, 2026
traded Jan 5, 2026
+1d
SEC Form 4

Evidence

22
HF
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
BCYCBICYCLE THERAPEUTICS PLC
Open-market sale
SELL$15K
2,367 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

22
RV
Raghavan VaidyanathanChief Technology Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$153K
2,291 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

22
LM
Lin MarkEVP and CFO
SMTCSEMTECH CORP
Open-market sale · 10b5-1 plan
SELL$102K
1,333 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

22
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$5.66M
122.4K sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

21
MB
Mulligan BrendanGeneral Counsel and Secretary
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$162K
4,366 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

21
VS
Voskanian ShauntChief Revenue Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$83K
2,200 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

21
MB
Mulligan BrendanGeneral Counsel and Secretary
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$125K
3,344 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

21
VS
Voskanian ShauntChief Revenue Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$73K
1,936 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

21
VS
Voskanian ShauntChief Revenue Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$74K
1,997 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

21
KS
Kosaraju SheelaSVP and General Counsel
CIENCIENA CORP
Open-market sale · 10b5-1 plan
SELL$421K
1,748 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

21
MB
Mulligan BrendanGeneral Counsel and Secretary
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$127K
3,449 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

21
HT
Herb TylerChief Accounting Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$90K
2,440 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

21
VS
Voskanian ShauntChief Revenue Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$231K
6,249 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

18
SS
Sahni Sanjeev SinghPresident
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$189K
2,828 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

18
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$103K
2,595 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

18
MB
Mulligan BrendanGeneral Counsel and Secretary
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$49K
1,300 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

18
HT
Herb TylerChief Accounting Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$45K
1,186 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

18
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$93K
2,405 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

18
HT
Herb TylerChief Accounting Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$45K
1,222 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

18
HT
Herb TylerChief Accounting Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$15K
400 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

18
SS
Sahni Sanjeev SinghPresident
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$64K
941 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

17
MP
Mazzara PhilipGeneral Counsel and Secretary
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$411K
2,304 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

17
MP
Mazzara PhilipGeneral Counsel and Secretary
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$462K
2,577 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

16
KR
Kelleher Eric RobertSee Remarks
OKTAOkta, Inc.
Open-market sale · 10b5-1 plan
SELL$34K
400 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

16
KR
Kelleher Eric RobertSee Remarks
OKTAOkta, Inc.
Open-market sale · 10b5-1 plan
SELL$26K
300 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

15
RV
Raghavan VaidyanathanChief Technology Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$22K
339 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

15
RV
Raghavan VaidyanathanChief Technology Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$9,132
145 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

15
SS
Sahni Sanjeev SinghPresident
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$18K
285 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

15
RV
Raghavan VaidyanathanChief Technology Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$23K
361 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

15
RV
Raghavan VaidyanathanChief Technology Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$29K
434 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

15
SS
Sahni Sanjeev SinghPresident
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$25K
392 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

14
MP
Mazzara PhilipGeneral Counsel and Secretary
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$237K
1,319 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

14
MP
Mazzara PhilipGeneral Counsel and Secretary
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$235K
1,300 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

14
MP
Mazzara PhilipGeneral Counsel and Secretary
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$104K
600 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

14
MP
Mazzara PhilipGeneral Counsel and Secretary
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$88K
500 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

14
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$60K
899 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

14
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$163K
2,500 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

14
MP
Mazzara PhilipGeneral Counsel and Secretary
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$192K
1,100 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

11
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$8,722
137 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence